Why the study?
Does prophylactic low molecular weight dextran prevent thromboembolism in patients undergoing elective surgery of the hip?
Does prophylactic low molecular weight dextran prevent thromboembolism in patients undergoing elective surgery of the hip?
Prophylactic administration of low molecular weight dextran is effective and safe for preventing thromboembolism after elective hip surgery.
Answers are grounded in this paper and cite their sources.
May support dextran prophylaxis after elective hip surgery; leaves open confirmation in randomized trials.
A high incidence (53.6 per cent) of venous thrombosis occurs after elective surgery of the hip. 2. The diagnosis of venous thrombosis by clinical signs and symptoms is far less sensitive than by venography. 3. Low molecular weight dextran has a marked protective effect against the occurrence of thromboembolism as demonstrated in a controlled study of 106 elective hip operations. 4. Low molecular weight dextran has been shown to be safe as well as effective. 5. The prophylactic administration of low molecular weight dextran is recommended for patients undergoing elective surgery of the hip.
No takes yet. Share an insight, caveat, or question.
Evarts et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: